Combination of AZD2281 (Olaparib) and GX15-070 (Obatoclax) results in synergistic antitumor activities in preclinical models of pancreatic cancer.
Cancer Lett
; 348(1-2): 20-8, 2014 Jun 28.
Article
in En
| MEDLINE
| ID: mdl-24534203
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Cancer Lett
Year:
2014
Document type:
Article
Affiliation country:
China
Country of publication:
Ireland